Friday, April 21, 2017

CORRECTED-U.S. FDA approves Samsung Bioepis' copy of J&J's Remicade - company

* Latecomer invested $1.3 bln in biosimilar development so far

by reutersCOMPANYNEWS via Endless Supplies .Biz - News
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)